At Sarcomatrix, we are pioneering treatments that address the root cause of muscle wasting diseases like sarcopenia, cachexia and muscular dystrophies. Our innovative approach combines gene-modifying oral drugs and protein replacement via IV, offering a potential cure rather than just symptom management. This positions us uniquely in a market where there are no cures and existing treatments fall short.